Cancer chemo patients improve quality of life; complex sugar drug DAVANAT proven in four FDA trials*

In four FDA trials, 97 cancer patients were dosed with a combination of chemotherapy and DAVANAT. During the trials, patients taking DAVANAT experienced significantly fewer serious side effects of chemotherapy including mucositis, gastrointestinal problems, loss of hair, nausea and vomiting according to Pro-Pharmaceuticals, Inc. DAVANAT targets the chemo into the tumors thereby protecting the healthy cells and reducing the chemo¹s side effects.